KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Opko Health (OPK) Shares Outstanding (2016 - 2025)

Opko Health (OPK) has disclosed Shares Outstanding for 16 consecutive years, with $789.9 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Shares Outstanding rose 12.63% year-over-year to $789.9 million, compared with a TTM value of $789.9 million through Dec 2025, up 12.63%, and an annual FY2025 reading of $789.9 million, up 12.63% over the prior year.
  • Shares Outstanding was $789.9 million for Q4 2025 at Opko Health, down from $798.9 million in the prior quarter.
  • Across five years, Shares Outstanding topped out at $809.6 million in Q2 2025 and bottomed at $8.7 million in Q1 2022.
  • Average Shares Outstanding over 5 years is $685.3 million, with a median of $712.3 million recorded in 2024.
  • The sharpest move saw Shares Outstanding soared 125400.86% in 2022, then decreased 10.31% in 2024.
  • Year by year, Shares Outstanding stood at $8.7 million in 2021, then surged by 8927.14% to $781.3 million in 2022, then rose by 0.08% to $781.9 million in 2023, then dropped by 10.31% to $701.4 million in 2024, then grew by 12.63% to $789.9 million in 2025.
  • Business Quant data shows Shares Outstanding for OPK at $789.9 million in Q4 2025, $798.9 million in Q3 2025, and $809.6 million in Q2 2025.